Petition Closed
Petitioning The U.S. House of Representatives

Bipartisan Congressional Sign-On Letter circulating in House of Representatives

Right now is a unique window of opportunity to end the federal government's decades-long stranglehold on research into marijuana's potential as an FDA-approved prescription medicine. On May 15, 2007, DEA Law Judge Mary Ellen Bittner issued an Opinion and Recommended Ruling to DEA in favor of Prof. Craker's application to grow research-grade marijuana at the University of Massachusetts--Amherst. Prof. Craker's facility would end NIDA's decades-long monopoly on the supply of marijuana that can be used in FDA-approved research, and is the focal point of the struggle to bring medical marijuana before the FDA to evaluate whether it meets federal standards for safety and efficacy as a prescription medicine.

Letter to
The U.S. House of Representatives
I would like to encourage you to sign John Olver and Dana Rohrabacher's Congressional Sign-on letter to the DEA in support of Professor Lyle Craker's application for a Schedule I license to produce research-grade marijuana for FDA- and DEA-approved clinical studies. I would like to see the controversy over medical marijuana resolved through privately-funded FDA-approved research, and Prof. Craker's case is the focal point of the struggle to evaluate whether medical marijuana meets the FDA's standards for safety and efficacy. Thank you for your time and consideration.